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Results

SynGAP isoforms have distinct and overlapping expression profiles during brain development
SΥΝGAP1 is alternatively spliced at several sites to include exons 18, 19, or 20 to generate four unique C-terminal isoforms: SynGAP-α1, SynGAP-α2, SynGAP-β, and SynGAP-γ (Fig. 1A, B) . SynGAP-α1 and SynGAP-α2 isoforms skip exon 19 and are produced by selective splicing of exon 20, whereby SynGAP-α1 contains a PDZ ligand (-QTRV) and SynGAP-α2 lacks this domain. The SynGAP-β isoform includes a frameshifting extension of exon 18 leading to early termination, which generates a SynGAP protein with a partially truncated coiled-coil domain. The SynGAP-γ isoform includes exon 19, which contains a short coding sequence followed by a STOP codon (-LLIR*).
To characterize each SynGAP isoform, we raised antibodies using SynGAP C-terminal peptides as antigens (Fig. 1B , black underlines). Antibody specificity was validated in transfected HEK cells ( Fig. 1A ). All four SynGAP isoforms are enriched in brain tissue (* asterisks: non-specific band) with other brain-specific proteins, such as Stargazin and TARP-γ8 (Fig. 1D , and quantification in Supplementary   Fig. 1B ). To determine the expression profile of SynGAP isoforms, we isolated 8 brain regions from adult (P42) mice. All four SynGAP isoforms are enriched in forebrain regions such as the cerebral cortex and hippocampus in comparison to hindbrain structures such as the pons (Fig. 1E , quantification in Supplementary Fig. 1C ). However, there are several isoform-specific differences in regional expression.
For example, SynGAP-β and SynGAP-γ are also expressed in the olfactory bulb, and SynGAP-γ is expressed at a significant level in the cerebellum. SΥΝGAP1 mutations have been linked to NDDs such as ID and ASD, which suggests an important role for SΥΝGAP1 in normal brain development. Thus, we sought to investigate the expression of the SynGAP isoforms throughout development in brain tissue from mice at several developmental stages spanning late embryogenesis to adulthood ( Fig. 1F-H , Araki Y and Huganir RL et al 9 complete set of quantification in Supplementary Fig. 1D ). SynGAP-β is well expressed early in development (E18-P14) whereas SynGAP-α2 is generally the most abundant isoform and reaches maximal abundance at P21-P35. SynGAP-α1 expression increases later in development. (Fig. 1F-H) .
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Expression of other synaptic proteins (GluA1, PSD-95, and TARPs) reached maximum between P21 and P42, which is similar to the timeframe for maximal expression of SynGAP-α1 and SynGAP-α2.
In order to more rigorously quantify the expression levels of SynGAP isoforms over development, using standardized detection ratios of each isoform to total SynGAP based on Figure 1C , we calculated the relative abundance (% total SynGAP) of each isoform at P0 and P42 ( Fig. 1F-H ). SynGAP-β is relatively highly expressed at P0 (34.6 ± 0.6 %) and decreases to 15.7 ± 0.8 % at P42. SynGAP-α2
increases slower than the β isoform prenatally but is also expressed well at P0 (31.9 ± 0.4 %). The α2 isoform is the most abundant isoform at the P42 (44.9 ± 1.5 %), which is consistent with a previous finding that SynGAP-α2 is the dominant isoform at the mRNA level as well (Yokoi et al., 2017) . SynGAP-α1
exhibits relatively low expression levels at P0 (24.3 ± 0.3 %) and then accumulates throughout development, eventually becoming the second most highly-expressed isoform when measured at P42
(35.0 ± 0.9 %) next to the α2 isoform. SynGAP-γ is expressed at low levels throughout development (9.1± 0.5 % at P0, and 4.3 ± 0.3 % at P42) (Fig. 1H) .
To extend our protein-level observations and investigate the correspondence to human SYNGAP1, we analyzed previously published human brain RNAseq data (n = 338) (Jaffe et al., 2018) ( Fig. 1I ,J, Reads per 80 million mapped (RP80M) in Supplementary Fig. 1E , F). Consistent with our biochemical estimates, splice junctions that lead to the β isoform comprised ~22% of all reads spanning the exon 17-18 junction and decreased slightly across development ( Fig. 1G) . At the α1/ α2/γ junction, which is relevant in the non-β transcripts (the remaining 78%), we observe that junction reads corresponding to the α2 isoform are the most abundant across all ages (~56% of reads spanning exon 18 to 19/20 junctions), and the α1 isoform follows at ~35%, increasing slowly throughout development, while the γ isoform junction reads are rare (~9% of non-β) (Fig. 1J ). This correspondence with protein Araki Y and Huganir RL et al 10 data shows that the SynGAP isoform abundance levels are tightly controlled on the level of splicing and the ratios across development are conserved in mice and humans. Therefore, we next tested whether these isoforms have unique neuronal functions and play distinct roles in SYNGAP1-related pathogenesis.
Unique LLPS propensities of SynGAP isoforms correlate with their localization to the cytoplasm or the post-synaptic density
To better understand isoform-specific function in neurons, we first investigated differences in liquid-liquid phase separation (LLPS), a mechanism for the effective subcellular organization of cellular proteins. We previously discovered that SynGAP-α1 undergoes LLPS with PSD-95 at physiological concentrations in vitro, resulting in the concentration of SynGAP into dense condensates that are reminiscent of the postsynaptic density (Zeng et al., 2016) . To investigate the biochemical and phase separation
propensities of other SynGAP isoforms, we first performed a sedimentation assay in HEK cells transfected with constructs encoding tagged full-length PSD-95 and SynGAP ( Fig. 2A) Supplementary Fig 2A) . Co-expression of both myc-PSD-95 and GFP-SynGAP-α1 WT causes a dramatic increase in their concentration in the phase-separated [P] fraction (80.3 ± 2.2 % of PSD-95 and 74.7 ± 3.3 % of SynGAP-α1 in the condensed phase fraction when co-expressed, *** p < 0.001 compared to expressed alone). We previously generated a mutant form of SynGAP-α1 that contains two point mutations in SynGAP-α1 -L1202D and K1252D (GFP-SynGAP-α1 LDKD) (Zeng et al., 2016 LDKD with PSD-95 was significantly decreased in the [P] fraction when compared to that of GFPSynGAP-α1 WT with PSD-95 (44.0 ± 5.0 % of PSD-95 and 27.3 ± 4.6 % of SynGAP-α1 LDKD at condensed phase fraction when SynGAP-α1 LDKD and PSD-95 was co-expressed, *** p < 0.001 compared to SynGAP-α1 WT and PSD-95 was co-expressed, Supplementary Fig 2A) . We also determined the PDZ ligand (QTRV) of SynGAP-α1 is critical for efficient phase separations in this assay ( Supplementary Fig. 2B , Phase separation index: 80.0 ± 3.8 % of PSD-95 when co-expressed with SynGAP-α1, but 49.7 ± 2.7 % of PSD-95 when co-expressed with SynGAP-α1 ΔQTRV, ** p< 0.01).
These data are consistent with the results of in vitro, cell-free sedimentation assay experiments reported previously (Zeng et al., 2016) .
We next examined the propensity of each SynGAP isoform to undergo LLPS with PSD-95 ( Fig.   2B , C, and Supplementary Fig 2C) . Expressed separately, all individual isoforms were preferentially found in the soluble fraction. Co-expression of individual SynGAP isoforms with PSD-95 dramatically increased the presence of both GFP-SynGAP-α1 and myc-PSD-95 in the phase-separated fraction (71.0 ± 1.4 % of SynGAP-α1 in condensed phase fraction when co-expressed with PSD-95). Similarly, GFPSynGAP-α2 and GFP-SynGAP-γ also exhibited an increased localization in pellet fraction, albeit to a lesser extent than that of GFP-SynGAP-α1 (50.8 ± 0.9 % of SynGAP-α2 and 53.3 ± 0.5 % of SynGAP-γ in condensed phase fraction when co-expressed with PSD-95, Fig. 2B , C, and Supplementary Fig 2D) These isoforms harbor a complete coiled-coil domain but lack the PDZ ligand. In contrast, GFP-SynGAP-β and myc-PSD-95 did not efficiently co-sediment (36.2 ± 2.5 % of SynGAP-β in condensed phase fraction when co-expressed with PSD-95. *** p < 0.001, compared to SynGAP-α1 coexpressed with PSD-95). SynGAP-β lacks the PDZ ligand and contains only a partial coiled-coil domain. These results highlight the necessity and additive functions of the coiled-coil domain and PDZ ligand in mediating
SynGAP isoform interactions and binding to PSD-95.
We next used confocal microscopy to assess SynGAP isoform-dependent biomolecular condensate formation in living HEK cells (Supplementary Fig 2D) . We previously reported that GFPSynGAP-α1 and RFP-PSD-95 undergo LLPS in living cells and form liquid-like cytoplasmic droplets when expressed in living cells (Zeng et al., 2016) . When expressed alone in HEK 293T cells PSD95-mCherry (PSD95-mCh) exhibited relatively diffuse cytoplasmic expression (4.8 ± 1.0 % of PSD-95 puncta positive cells). In contrast, co-expression of PSD95-mCh and GFP-SynGAP-α1 WT led to a dramatic increase in distinct cytoplasmic puncta (> 1 μm diameter) (85.5 ± 3.3 % of PSD-95 puncta positive cells when coexpressed, *** p < 0.001 compared to PSD-95 alone). However, GFP-SynGAP-α1 LDKD did not induce puncta formation when co-expressed with PSD-95-mCh (22.3 ± 5.3% of PSD-95 puncta positive cells, *** p < 0.001 compared to SynGAP-α1 WT and PSD-95 was co-expressed) ( Supplementary Fig. 2D ).
We next determined the percentage of cytoplasmic puncta-positive cells following co-expression of PSD-95-mCh along with each SynGAP isoform. SynGAP-α1 expression robustly induced distinct puncta with PSD-95 (88.2 ± 4.9 % of PSD-95 puncta positive cells when SynGAP-α1 and PSD-95 were coexpressed)
that were absent with expression of all other SynGAP isoforms (7.3 ± 2.3 %, 6.0 ± 4.3%, 9.0 ± 3.9 % when SynGAP-α2, β,γ and PSD-95 were co-expressed respectively, *** p < 0.001, compared to SynGAP-α1 and PSD-95 co-expression) (Fig. 2D, E) . The failure of non-SynGAP-α1 isoforms to induce the formation of measurable cytoplasmic puncta suggests that a complete coiled-coil domain and PDZ-ligand are necessary for the LLPS of SynGAP in this assay. These results suggest that SynGAP isoforms have unique LLPS properties that are determined by their C-terminal sequences.
Finally, we examined biochemical distributions of SynGAP isoforms in the mouse brain ( Fig. 2F- H, complete set of quantification in Supplementary Fig. 2E ). Mouse brains were excised and fractionated into Total (Total homogenate), S2 (13,800 x g Supernatant), SPM (Synaptosomal plasma membrane), and PSD (Post-synaptic density). Almost SynGAP isoforms were highly enriched in PSD fractions (α1 7.1 ± 0.5 fold enrichment, α2 6.3 ± 0.2 fold enrichment, β 3.6 ± 0.2 fold enrichment, γ 4.6 ± 0.3 fold enrichment). However, the SynGAP-β isoform was significantly less enriched in PSD (*** p < Fig. 3A-C) . SynGAP-β possesses the highest GAP activity among all isoforms (50.6 ± 3.7 % decrease in Ras-GTP, 53.3 ± 6.7 % decrease in Rap1-GTP, 39.2 ± 2.7 % decrease in Rac1-GTP) (Fig. 3D, E) . SynGAP-α1 preferentially activate GTPhydrolysis of Ras (28.2 ± 2.8 % decrease in Ras-GTP), compared to Rap1 (14.3 ± 4.3 % decrease in Rap1-GTP, * p < 0.05 compared to Ras) (Fig. 3D, E) . SynGAP-α2 has a similar trend to decrease Ras-GTP over Rap1-GTP (37.0 ± 3.5 % decrease in Ras-GTP, compared to 24.8 ± 1.0 % decreases in Rap1-GTP, p = 0.06). Conversely, SynGAP-β highly activates GTP hydrolysis of Rap1 with similar levels with Ras (53.2 ± 6.8 % decreases in Rap1-GTP, compared to 50.6 ± 3.8 % decreases in Ras-GTP) ( Fig.   3D,E) . Since small G proteins were not phase-separated, the most soluble SynGAP-β isoform may have the highest exposure to cytosolic small G-proteins, and thus, have the highest GAP activities. It is also possible that different C-terminal structures enhance or decrease the accessibility of various small G proteins to the GAP domain and thus differentially regulate their GAP activity.
Differential dispersion dynamics of SynGAP isoforms during LTP
Previously, we have shown that SynGAP-α1 undergoes rapid NMDAR-CaMKII-dependent dispersion from the synapse, which is required for AMPAR insertion and spine enlargement during LTP (Araki et al., 2015) . In order to investigate the dispersion dynamics of the other SynGAP isoforms during LTP, we employed a knockdown-replacement strategy in cultured hippocampal neurons, whereby endogenous SynGAP expression was depleted via shRNA-mediated knockdown and individual GFP-tagged, shRNAresistant SynGAP isoforms were transfected (Fig. 4) . We knocked down 77.3 % ± 0.1 % of endogenous SynGAP by shRNA and replaced with similar amount (-90% of endogenous proteins) by shRNA resistant SynGAP isoform construct ( Supplementary Fig. 3 ). Cultured neurons were subjected to a chemical LTP (chemLTP) treatment during live confocal imaging, and the amount of synaptically localized GFP-tagged SynGAP as well as dendritic spine size were measured before and after LTP (Fig. 4A, B) . In this chemLTP stimulation, the magnesium in the media was withdrawn in conjunction with glycine perfusion.
With spontaneous glutamate release from axonal terminals, glycine strongly and specifically stimulates synaptic NMDA receptors (Liao et al., 2001; Lu et al., 2001) . SynGAP-α1 exhibited high synaptic localization prior to LTP induction and then underwent rapid dispersion following LTP (3.5 ± 1.3 fold synaptic spine enrichment of SynGAP-α1 before chemLTP, 1.7 ± 0.3 fold synaptic spine enrichment after chemLTP, *** p < 0.001) (Fig. 4A, B) . GFP-SynGAP-α2 was also dispersed albeit to a lesser extent than GFP-SynGAP-α1 (2.8 ± 0.6 fold synaptic spine enrichment of SynGAP-α2 before chemLTP, 1.8 ± 0.4
fold synaptic spine enrichment after chemLTP, * p < 0.05). In contrast, GFP-SynGAP-β is less enriched at synapses and fails to disperse upon chemLTP stimulation (1.9 ± 0.09 fold synaptic spine enrichment of SynGAP-α2 before chemLTP, 1.4 ± 0.11 fold synaptic spine enrichment after chemLTP, not significant p > 0.05). (Fig. 4A, B) . Taken together, these data indicate distinct dynamics for individual SynGAP isoforms such that SynGAP-α1 was most robustly dispersed during LTP and the β isoform was not.
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Synaptic AMPAR insertion and spine enlargement during LTP are differentially regulated by
SynGAP isoforms
We previously demonstrated that SynGAP-α1 undergoes rapid NMDAR-and CaMKII-dependent dispersion from the synapse, and this dispersion is required for synaptic AMPAR insertion and spine enlargement that occur during LTP (Araki et al., 2015) . So far, we have determined that various SynGAP isoforms have distinct phase separation propensities, have differential GAP activity, synaptic dendritic localization, and dispersion kinetics during LTP. Thus, we hypothesize these SynGAP isoforms function differentially during LTP. To test this hypothesis, we replaced endogenous SynGAP with shRNA-resistant Azurite-tagged SynGAP isoforms (Araki et al., 2015; Zeng et al., 2016) . Transfected neurons also expressed the pH-sensitive Super ecliptic pHluorin (SEP)-tagged-GluA1 (SEP-GluA1) and mCherry to monitor surface AMPAR expression and dendritic spine size in response to chemLTP treatment ( in SYNGAP1-shRNA + SynGAP-β expression) ( Fig. 5A4 and Fig. 5C -E). We previously found that the phase separation mutant of SynGAP-α1 (LDKD) only partially rescued the LTP and significantly lowered the LTP threshold (Zeng et al., 2016) . These results suggest that both the coiled-coil domain and PDZ ligand are required for LTP rescue in SynGAP KD neurons, and only SynGAP-α1 harbors the necessary and sufficient domains for efficient LTP expression. Our data suggest a specialized role for SynGAP-α1 in regulating LTP.
Dendritic arbor development is regulated by select SynGAP isoforms
Since our data reveal only modest roles for non-α1 isoforms in regulating synaptic plasticity in contrast to the differences in G-protein activity-regulation, we decided to investigate whether SynGAP isoforms are involved in other aspects of neuronal function. A previous report showed that Syngap1 +/-mice have a significantly altered dendritic arborization pattern (Aceti et al., 2015) . Thus, we assessed the effects of specific SynGAP isoforms in regulating dendritic development. In this experiment, the effects of SΥΝGAP1 knockdown on dendritic branching was assessed by comparing control and SYNGAP1
shRNA-expressing hippocampal neurons at DIV 8 (Fig. 6A) . Obvious basal (< 10-50 μm in length) dendrites (Control: 3.4 ± 0.5 intersections at 10 μm) and a branched primary apical (>100-150 μm in length) dendrites emanate from the somas of control neurons (Control: 4.2 ± 0.3 intersections at 150 μm).
Sholl analysis revealed that SYNGAP1 knockdown aberrantly enhances the number of neurite extensions proximal to neuronal cell bodies (8.3 ± 0.8 interactions at 10 μm, *** p < 0.001 compared to Control 3.4 ± 0.5 intersections at 10 μm) (Fig. 6B, F) . In contrast, SYNGAP1 knockdown significantly decreased distal branches (SYNGAP1-shRNA : 0.3 ± 0.2 intersections at 150 μm, *** p < 0.001 compared to Control : 4.2 ± 0.3 intersections at 150 μm) (Fig. 6B, F) . The aberrantly elevated outgrowth of neurites proximal to neuron somas that is associated with SYNGAP1 knockdown was rescued by expressing all SynGAP isoforms (α1 rescue : 4.0 ± 0.5 intersections at 10 μm, α2 rescue : 3.0 ± 0.3 intersections at 10 μm, β rescue : 3.7 ± 0.5 intersections at 10 μm, γ rescue 4.3 ± 0.2 intersections at 10 μm, *** p < 0.001 compared to SYNGAP1-shRNA : 8.3 ± 0.8 interactions at 10 μm) (Fig. 6C, G) . Interestingly, only
SynGAP-β effectively rescued the distal dendritic complexity deficits (150 μm) by restoring the formation of primary and secondary apical dendrites (β rescue : 3.8 ± 0.6 intersections at 150 μm *** p < 0.001 compared to SYNGAP1-shRNA 0.3 ± 0.2 intersections at 150 μm). All other α1, α2, and γ isoforms failed to rescue distal branching deficits (α1 rescue : 1.7 ± 0.4 intersections at 150 μm, α2 rescue : 1.3 ± 0.2 intersections at 150 μm, γ rescue : 1.0 ± 0.3 intersections at 150 μm, not significant compared to SYNGAP1-shRNA : 0.3 ± 0.2 interactions at 150 μm) (Fig. 6C, G) . Interestingly, expression of SynGAP-α1 LDKD rescued the primary dendrite phenotype, similar to the effect of expression of SynGAP-β (α1 LDKD rescue : 3.5 ± 0.4 intersections at 150 μm *** p < 0.001, β rescue : 3.8 ± 0.6 intersections at 150 μm ***p < 0.001, compared to SYNGAP1-shRNA : 0.3 ± 0.2 intersections at 150 μm) (Fig. 6C, D 
, H).
This result suggests that disruption of SynGAP-α1 LLPS results in more β like behavior, rescuing distal dendritic arbor deficits. Finally, we found that a GAP mutant of SynGAP (Araki et al., 2015) does not rescue the dendritic arbor deficits (α1 GAP* rescue : 7.7 ± 1.2 intersections at 10 μm, not significant compared to SYNGAP1-shRNA : 8.3 ± 0.8 interactions at 10 μm), indicating that GAP activity is required for the dendritic phenotype rescue described here (Fig. 6E, F) .
Discussion
Here, we have characterized the developmental expression and subcellular localization, biochemical
properties, and functional roles of each C-terminal SynGAP splice variant. Our data suggest novel roles for SynGAP isoforms in regulating dendrite and synapse development in neurons. SynGAP-β is expressed at higher portions early in brain development, and is gradually replaced in the mature brain by increasing expression of SynGAP-α1 and SynGAP-α2. Although SynGAP-β appears dispensable for synaptic plasticity function, it exhibits the strongest GAP activity of all the C-terminal isoforms, preferentially targets Rap1, and facilitates dendritic arbor development. SynGAP-β not only lacks a PDZ ligand, but also lacks a full coiled-coil domain, likely leading to the dramatically reduced LLPS propensity and increased cytoplasmic localization. SynGAP-α1, however, contains a complete coiled-coil domain and PDZ ligand, leading to the strongest LLPS and robust concentration at the PSD and is critical for LTP expression. This dense packing in the PSD in turn may be important to allow the dynamic dispersion of SynGAP during LTP (Fig. 7Α) , which we have shown earlier to be required for both spine growth and AMPAR trafficking (Araki et al., 2015) . The LLPS mutant of SynGAP-α1 failed to rescue synaptic plasticity but instead rescued dendritic arbor development like SynGAP-β, suggesting that LLPS propensity determines the roles of SynGAP in the regulation of neuronal maturation and/or synaptic plasticity.
SynGAP-β: early expression and strongest GAP function -Roles in dendritic development and its implications on neurodevelopmental disorders
In the present study, we discovered that knockdown of SynGAP results in excessive proximal dendritic sprouting in immature hippocampal neurons, and importantly, SynGAP-β effectively rescues this developmental phenotype. Various small G proteins such as Ras, Rap1, Rac1, and RhoA tightly regulate dendritic arbor development by precisely controlling the number and length of dendritic branches (Fu et al., 2007; Nakayama et al., 2000; Saito et al., 2009; Sepulveda et al., 2010) . For example, Rap1
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19 increases proximal dendritic branching in rat cortical neurons, and Rap2 activation decreases the length and complexity of developing axonal and dendritic branches (Chen et al., 2005) . These data link our observed dendritic phenotype caused by SYNGAP1 deficiency to regulation of small G-proteins. Further, dominant-negative forms of Rac1 decrease proximal dendritic branching and increase distal dendritic branching in hippocampal organotypic slice cultures, suggesting that a proper balance of small G-protein activation is crucial for normal dendritic development (Nakayama et al., 2000) . Additionally, the Ras-PI3K-Akt-mTOR pathway controls somatic and dendritic sizes and coordinates with Ras-mitogenactivated protein kinase signaling to maintain dendritic complexity (Kumar et al., 2005) . Thus, it is possible that SYNGAP1 haploinsufficiency causes overactivation of Ras and Rap1 and consequently disrupts the balanced signaling required for normal dendritic development. Our results suggest that SynGAP-β plays pivotal role in establishing this balance by regulating Rap1 and other small G proteins.
There are currently a variety of available downstream inhibitors of small G proteins, which may prove to be valuable therapeutic targets to decrease dendritic deficits caused by SynGAP-β deficiency.
Recent studies have suggested that human induced pluripotent stem cells (hiPSCs) derived from ASD patients exhibit accelerated dendritic outgrowth and excessive dendritic branching following neuronal differentiation (Schafer et al., 2019) . These observations, together with our finding that SynGAP-β predominantly promotes dendritic arbor development, links dendritic morphological deficits to the abnormal neuronal wiring associated with NDDs.
Critical role of SynGAP-α1 in synaptic plasticity; strong LLPS propensity for synaptic enrichment and dispersion during LTP
We have previously reported that SynGAP-α1 is rapidly dispersed in response to LTP-inducing synaptic activity. This dispersion allows for AMPAR insertion into the synaptic membrane and for enlargement of dendritic spines. Thus, SynGAP-α1 functions to regulate AMPAR accumulation and spine size at basal Araki Y and Huganir RL et al 20 states to maintain a neuron's ability to undergo LTP and avoid saturating plasticity (Araki et al., 2015; Zhu et al., 2002) . Here, we demonstrate that only the SynGAP-α1 isoform efficiently drives AMPAR insertion and spine enlargements during LTP. SynGAP-α1 is highly concentrated in the PSD via LLPS with PSD-95, which generates a sharp concentration gradient of SynGAP in dendritic spines that is collapsed following activity-dependent SynGAP-α1 dispersion and subsequent synaptic potentiation (Araki et al., 2015; Dosemeci and Jaffe, 2010; Lautz et al., 2018; Lautz et al., 2019; Yang et al., 2013; Yang et al., 2011) . We speculate that the high magnitude of activity-dependent dispersion of SynGAP-α1 is due, in part, to the tendency of SynGAP-α1 to robustly phase separate with PSD95 and facilitate LTP-associated signaling in the synapse. Mice with Syngap1 haploinsufficiency display exaggerated synaptic connectivity and E/I balance in CA1 excitatory neurons (Clement et al., 2012) . These may be a result mainly from α1 specific haploinsufficiency as SynGAP-α1 strongly regulates synaptic function compared to other isoforms.
Regulation of neuronal function by distinct SynGAP isoforms
LLPS propensity of SynGAP isoforms determines its function and GAP activity in neurons
In the present study, an LLPS mutation of the α1 isoform switched its functional outcome from rescuing synaptic plasticity (α1-type) to rescuing dendritic arborization (β type) after SynGAP knockdown, suggesting that distinct structural and LLPS propensities of SynGAP isoforms define roles in regulating neuronal development and/or synaptic plasticity. In addition, we previously showed that SynGAP-α1 LDKD mutant, with its weaker LLPS propensity, is not able to fully rescue knockdown-dependent aberrant synaptic strengthening, and that this rescue results in altered and abnormally lowered LTP threshold (Zeng et al., 2016) . Taken together, these results suggest that the LLPS propensity of SynGAP alter its function in neurons and determines between the α1 or β like behavior of the molecules.
As we have shown, the SynGAP isoforms differentially regulate small G-proteins. These results may be due to differences in the localization of the SynGAP isoforms, since rates of biochemical reactions Araki Y and Huganir RL et al 21 are dependent on the concentration of reactants within a microenvironment. LLPS of SynGAP physically separates its GAP domain within SynGAP from the small G proteins. This is consistent with our observation that while SynGAP-β generally showed the weakest LLPS but has the highest GAP activity towards almost all small G-proteins (Fig. 7B) . It is known that various GAPs are also differentially localized by distinct lipid modifications. After synthesis of Ras, Rap1, and Rac1, farnesyl or geranylgeranyl moieties are attached to the C-terminal 'CAAX' motifs (C: Cys; A: an aliphatic amino acid, X: M, Q, S, T, or A for farnesyl, L or I for geranylgeranyl) for membrane tethering, facilitating interaction with effector molecules at the proximity of the membrane. The various small G proteins have slightly different CAAX motifs that are susceptible to distinct modifications (For example, H-Ras has CVIM for farnesylation, Rap1a has CLLL for geranylgeranylation) and thus differentially targeted to cellular microenvironments (Moores et al., 1991; Simanshu et al., 2017; Wright and Philips, 2006) . Thus, the combinations of small G-protein localization and SynGAP isoform localization may define the ability of each SynGAP isoform to activate distinct GTPase activation, and thus differentiate their function in synaptic spines or dendrites.
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Importance of characterizing various SynGAP isoforms to elucidate ID/ASD pathogenesis:
Therapeutic strategies for MRD5 and neurodevelopmental disorders SYNGAP1 is the 4th most prevalent gene that is mutated in neurodevelopmental disorders (NDD) such as ID/ASD. Mutation of SYNGAP1 explains ~0.75% of all NDD cases which is nearly as high as prominent X-linked disorders, such as the Fragile X syndrome (UK-DDD-study, 2015). SYNGAP1 is located in the 6p21 region, near the major immuno-histocompatibility complex (MHC) where a high rate of sequence variability is observed between people (Reche and Reinherz, 2003; Sommer, 2005) . This high rate of variability within genomic regions, along with the fact that SYNGAP1 does not have neuronal homologs despite its critical roles in development and plasticity, may contribute the high rate of
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22 association of SYNGAP1 with MRD5 in ID/ASD populations. We highlight the importance of SynGAP-α1
in synaptic plasticity and suggest that correcting the exaggerated downstream activity due to haploinsufficiency of α1 might be beneficial for the patients. In this paper, we characterized dynamic changes in the expression profile of SynGAP isoforms in the brain throughout development. We showed that SynGAP-α1 expression accounts for only 25~35% of total SynGAP, highlighting the importance of assessing the function of all isoforms to understand the pathogenesis of MRD5. We also found SynGAP-β to be expressed earliest in development, and to play a unique role in dendritic arbor development.
Further characterization of downstream small G proteins and kinases that have pivotal roles in dendritic development will lead to unique targets for treating the aberrant neuronal wiring that is associated with MRD5 as well as other ID/ASD-related neurodevelopmental disorders.
Materials and Methods
Reagents
All restriction enzymes were obtained from New England Biolabs. Chemicals were obtained from SIGMAAldrich unless otherwise specified. TTX, Bicuculline, and Strychnine were obtained from TOCRIS Bioscience. Goat anti-SynGAP-α1 antibody is from Santa Cruz (sc-8572). Rabbit pan-SynGAP 947-1167
antibody is from Thermo scientific (#PA-1-046). DNA sequencing was performed at the Johns Hopkins University School of Medicine Sequencing Facility.
Antibodies
The rabbit anti-SynGAP-α1 antibody was used as described in previous reports (Kim et al., 1998; Rumbaugh et al., 2006) . To raise antibodies that specifically recognize each non-α1 SynGAP isoform, we conjugated 10-18 amino acids of the C-terminal sequences of each SynGAP isoform with an Nterminal Cysteine (CPPRLQITENGEFRNTADH (JH7265, α2), CGGGGAAPGPPRHG (JH7266, β), and CRLLDAQLLIR (JH7366, γ)) to Keyhole limpet hemocyanin (PIERCE) using the manufacturer's protocol.
Antisera acquired after 2 booster injections (α1, α2, β, and γ) were affinity purified using peptide coupling sulfolink-beads (PIERCE).
Human SYNGAP1 splicing analysis
Exon junction abundance data was acquired from Brain Seq Consortium Phase 1 (Jaffe et al., 2018).
Briefly, total RNA extracted from post-mortem tissue of the dorsolateral prefrontal cortex grey matter (DLPFC) was sequenced and reads were aligned with TopHat (v2.0.4) based on known transcripts of the Ensembl build GRCh37.67. Splice junctions were quantified by the number of supporting reads aligned by Tophat, and counts were converted to "RP80M" values, or "reads per 80 million mapped" using the total number of aligned reads across the autosomal and sex chromosomes (dropping reads mapping to the mitochondria chromosome), which can be interpreted as the number of reads supporting the junction
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For a given 5' splice donor site, all identified 3' splice acceptors were grouped together to calculate the relative abundance of each splice decision.
Liquid-liquid phase separation assay
HEK 293T cells were transfected with SynGAP and/or PSD-95 for 16 h. Cells were lysed in 0.5 ml of assay buffer (50 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.1% SDS, 0.5% Sodium deoxycholate, with cOmplete Protease inhibitor EDTA-free mix (Roche/ SIGMA)). Lysates were centrifuged at 15000 x g for 10 min at 4C. The supernatant-containing the soluble [S] fraction was collected. Pellets were resuspended and sonicated in 0.5 ml of assay buffer to obtain complete
For imaging of LLPS dynamics in living cells, HEK cells were grown on Poly-L-Lysine-coated glass coverslips. Cells were transfected with GFP-SynGAP and/or PSD-95-mCherry for 16 h before being placed in a custom-made live imaging chamber for observation under confocal microscopy. Cells were perfused with extracellular solution (ECS: 143 mM NaCl, 5 mM KCl, 10 mM Hepes pH 7.42, 10 mM Glucose, 2 mM CaCl 2, 1 mM MgCl2). For DAPI staining, cells were fixed with Parafix (4% paraformaldehyde, 4% Sucrose in PBS) for 15 min at room temperature, followed by incubating with 300 nM DAPI in PBS for 5 min at room temperature. Cells were briefly washed with PBS and mounted on slideglass. Cells were observed on an LSM880 (Zeiss) microscopy with a 40x objective lens (NA 1.3).
PSD fractionation
Fractionation of post-synaptic density (PSD) was performed as previously described (Kohmura et al., 1998) . In brief, mouse brains were collected and homogenized by 10-15 strokes of a Dounce A homogenizer in Buffer A (0.32M Sucrose, 10 mM Hepes (pH7.4) with cOmplete protease inhibitor mix (SIGMA)). The homogenate was centrifuged at 1,000 x g for 10 min at 4 °C. The supernatant (Post
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Nuclear Supernatant; PNS) was collected and centrifuged at 13,800 x g for 20 min at 4 °C. The pellet (P2 fraction) was re-homogenized in 3 volumes of Buffer A. The re-homogenized P2 fraction was layered onto a discontinuous gradient of 0.85, 1.0, 1.2 M sucrose (all containing 10 mM Hepes (pH7.4) plus cOmplete protease inhibitor mix), and were centrifuged at 82,500 x g for 2 h at 4 °C (Beckman SW28 swing rotor). The band between 1.0 and 1.2 M sucrose was collected as the synaptosome fraction and diluted with 80 mM Tris-HCl (pH 8.0). An equal volume of 1 % Triton X-100 was added and rotated for 15 min at 4 °C followed by centrifuging 32,000 x g for 20 min. The supernatant was collected as a Tritonsoluble synaptosome (Syn/Tx) fraction, and the pellet was re-homogenized in Buffer A by applying 10 passes through a 21G syringe. Equal amounts of protein (10 μg for immunoblotting) were used for further assay.
Chemical LTP and quantification
Live imaging and quantification of LTP were performed as described previously (Araki et al., 2015) .
Hippocampal neurons from embryonic day 18 (E18) rats were seeded on 25-mm poly-L-lysine-coated coverslips. The cells were plated in Neurobasal media (Gibco) containing 50U/ml penicillin, 50mg/ml streptomycin and 2 mM GlutaMax supplemented with 2% B27 (Gibco) and 5% horse serum (Hyclone).
At DIV 6, cells were thereafter maintained in glia-conditioned NM1 (Neurobasal media with 2mM
GlutaMax, 1% FBS, 2% B27, 1 x FDU (5mM Uridine (SIGMA F0503 
Dendritic arbor development assay
Cultured hippocampal neurons were plated on coverslips as described above and were co-transfected at DIV 3-4 with pSUPER-SynGAP shRNA and shRNA-resistant GFP-SynGAP-α1, α2, β, and γ replacement constructs. pCAG-DsRed2 was also co-transfected as a cell-fill for morphological analysis.
Neurons were fixed at DIV 8-9 by incubating them with Parafix (4% paraformaldehyde, 4% Sucrose in PBS) for 15 min at room temperature, followed by incubation with 300 nM DAPI in PBS for 5 min at room temperature. Cells were briefly washed with PBS and mounted onto glass slides. Cells were imaged with
Regulation of neuronal function by distinct SynGAP isoforms Araki Y and Huganir RL et al
27 a LSM880 (Zeiss) confocal microscope equipped with a 40x objective lens (NA 1.3) and GaAsP detectors.
To obtain Sholl profiles of dendritic arbors (Sholl, 1953) , images of entire dendritic arbors of hippocampal neurons expressing DsRed were acquired and processed using Image J (Fiji) software. Scholl analysis consisted of drawing concentric rings with radii of 10, 20, 30, 40, 50, 100, and 150 μm from the center of the cell body and counting the number of dendritic intersections across each concentric circle. If a branch point fell on a line, it was counted as two crossings (Nakayama et al., 2000) .
Small GTPase activity assay
Small GTPase activity was measured using a small GTPase-GTP pull-down assay. DNA constructs expressing a small G protein and a single SynGAP isoform were co-transfected into HEK cells for 48-72
hours. Active Ras levels were then assayed using a Ras activation assay kit (EMD Millipore). In brief, cells were lysed in Mg 2+ lysis/wash buffer (25 mM HEPES pH 7.5, 150 mM NaCl, 1% Igepal CA-630, 10 mM MgCl2, 1 mM EDTA, 10% glycerol), and active GTP-bound small G-proteins were pulled down using beads covalently bound to effector domains. After washing beads, active GTP-bound small G proteins were recovered through the addition of 2x SDS sample buffer followed by SDS-PAGE and subsequent immunoblotting for the various small G proteins.
Statistics
All data are expressed as means ± S.E.M. of values. One-way ANOVAs were used, followed by Tukey post hoc for multiple comparisons unless otherwise specified. If the interaction between two-factors was observed by two-way ANOVA, we performed individual Tukey post hoc tests to compare the measures as a function of one factor in each fixed levels of another factor unless otherwise specified. Statistical analyses and preparations of graphs were performed using SPSS 9.0, Excel 2010, or GraphPad Prism 4.0 / 5.0 software (*p < 0.05; **p < 0.01; ***p < 0.001). (B) Quantification of averaged relative change in the GFP-SynGAP isoform at synaptic spines following chemLTP treatment. Synaptic localization of SynGAP isoforms was determined by calculating the ratio of GFP intensity within dendritic spine heads and dividing by GFP intensity localized to the dendritic shaft at the base of the dendritic spine. Error bars indicate ± SEM. Two-way ANOVA followed by Tukey's post hoc test (SynGAP isoforms F(3,296) = 21.43 ; p < 0.0001, chemLTP F (1,296) = 119.9 ; p < 0.0001, Interaction F(3,296) = 6.607 ; p < 0.0001 , n = 37 -39 spines from 4 independent experiments, *** p<0.001, ** p<0.01, * < 0.05) was performed. Error bar indicates ± SEM. Endogenous SynGAP was knocked-down and replaced with individual Azurite-tagged SynGAP isoforms.
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Yellow arrows indicate dendritic spines that exhibited LTP-induced enlargement. Scale Bar, 5 μm. [SynGAP], p < 0.001; n = 47-49 spines from 4 independent coverslips each condition, *** p<0.001, ** p<0.01, * < 0.05) was performed. Error bar indicates ± SEM. SynGAP-α1 is tightly packed at PSD by phase separation and has the ability of low GTPase activations.
In contrast, SynGAP-β is less phase-separated and localized more in cytoplasmic region in synapses and dendritic shafts. It has a strong ability of GTPase activation. The phase-separation mutant of SynGAP-α1 LLPS*) behaves similarly to SynGAP-β. Protein Expression (Average of all age = 1) E 1 8 P 0 P 3 P 7 P 1 0 P 1 4 P 2 1 P 2 8 P 3 
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